Understanding the Invisible Threat: Mycoplasma Contamination in Cell Cultures | Webinar
Duration: 19 minutes
Overview
Mycoplasma contamination in cell cultures can severely compromise the reliability, consistency, and reproducibility of experimental results. Although it is one of the most common contaminants in cell culture, its prevalence is often overlooked. Mycoplasma can go undetected for months, even at high concentrations, because it is invisible to the naked eye. Therefore, regular testing of cell cultures is essential to prevent contamination and its spread.
Watch this webinar to explore the causes, challenges, and effective solutions for maintaining Mycoplasma-free cell cultures.
In This Webinar You Will Learn:
- Understanding Mycoplasma: An overview of Mycoplasma and common pathways for contamination in cell cultures
- Impact on Research: The impact of Mycoplasma on cells and the subsequent effects on the accuracy of scientific data
- Risk Minimization: Best practices to minimize the risk of Mycoplasma contamination in cell cultivation
- Detection Techniques: Methods for the rapid and reliable detection of Mycoplasma contamination
Webinar Speakers
Diana Patzelt
Global Product Manager, Microbiology, Sartorius
Dr. Diana Patzelt is a dedicated scientist with a passion for microbiology and infection research. Her education includes a Bachelor of Science degree in Biology, a Master of Science degree in Molecular Biology & Microbiology, and a Ph.D. in Infection Research.
After completing her postdoctoral education, Dr. Patzelt joined the R&D team at Sartorius where she developed innovative technologies and products to empower researchers to overcome challenges in microbial QC testing. Since 2021 she took responsibility of those products and technologies as global product manager Microbiology.
Sandra Söderholm
Application Development Scientist, Lab Essentials, Sartorius
Sandra Söderholm earned her PhD in Biochemistry from the University of Helsinki in 2016. In her thesis work, she investigated innate immune responses to Influenza A virus. After completing her PhD, she worked as a Post-Doctoral Researcher at Professor Dirk Bumann’s laboratory at Biozentrum (University of Basel, Switzerland), where she studied Pseudomonas aeruginosa and Staphylococcus aureus in clinical samples with mass spectrometry-based proteomics, to identify novel strategies to combat infectious disease and antibiotic resistance. She joined Sartorius as an Application Development Scientist in 2019.